Searched for
GLAND PHARMA DRUG
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...- Cenexi recovery, new product launches and capacity additions power Gland Pharma outlookGland Pharma stock surged to a 52-week high following robust March quarter and full-year results. Its European unit, Cenexi, is improving p...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Kedaara, TA Associates vie for minority stake in Sagent PharmaKedaara Capital and TA Associates are in talks to acquire a significant minority stake in Sagent Pharma, valued at $500-600 million. Invest...
- Gland Pharma's Hyderabad unit gets one observation from USFDA after inspection"This observation is procedural in nature and the corrective and preventive actions for this observation will be submitted to the USFDA wit...
- Gland says not heard from its promoter Fosun about the potential saleThe debt-laden Chinese conglomerate Fosun controlled by billionaire entrepreneur Guo Guangchang has been looking to sell non-core assets, t...
- Gland Pharma launches generic cancer treatment drug in USThe Hyderabad-based company said its product is therapeutically equivalent to Takeda Pharmaceuticals' Velcade for Injection.
- Smartkarma Research: APAC Healthcare Series - Top picks are poised for multi-year growthGland Pharma’s near-term focus remains on establishing a strong portfolio of complex injectables. The company is working on development of ...
- Gland Pharma gets tentative nod from USFDA for generic Sugammadex injectionThe company "has received tentative approval from the United States Food and Drug Administration (USFDA) for Sugammadex injection, 200 mg/2...
- Gland Pharma shares rally nearly 8%; at 52-week high after Q1 earningsDrug firm Gland Pharma on Wednesday reported an 11.83 per cent increase in its consolidated net profit to Rs 350.7 crore for the quarter en...
- Gland Pharma Q1 results: Net profit rises 12% to Rs 351 crConsolidated revenue from operations of the company stood at Rs 1,153.9 crore for the quarter under consideration. It was Rs 884.2 crore fo...
- Chinese firm-backed Gland Pharma files for IPO; may raise up to Rs 6,000 croreThe company may raise up to $800 million or Rs 6,000 crore, a source with the knowledge of the matter said.
- Blackstone, Strides, Nectar lead race for Orchid PharmaShares of Orchid closed at Rs 17 on Friday, down 5 per cent.
- Gland Pharma to leverage Fosun’s strengths for growthBiologics and biosimilar drugs are emerging hotspots, and Gland is arming itself to take a leap in this segment, which is estimated to be t...
- After Gland, Chinese pharma giant Fosun eyes API maker SymbiotecSymbiotec has been an acquisition target for other drug makers and PE players after the Indore-based company was put up for sale.
- Dr Reddy's joins hands with Gland Pharma to market 8 ANDAs in USDr Reddy's is developing its injectable business and recently launched Paricalcitol injection, a therapeutic equivalent generic version of ...
- Gland Pharma's deal with Fosun will open up new markets: Ravi Penmetsa, MD, Gland PharmaThe deal with Fosun is also an example of the excellence of India’s manufacturing capabilities. It goes with the essence of the Make in Ind...
- Hyderabad-based drugmaker Gland Pharma attracts bids from Torrent Pharma and BaxterIf the deal materialises, the promoter family of Ravi Penmetsa may sell its entire equity stake of nearly 60% for a valuation of over $1.2 ...
- Government clears KKR's proposal to buy stakes in Gland Pharma and Gland Celsus Bio ChemicalsGland Pharma makes and markets specialised injectable formulations for generic versions of drugs, it also manufactures a limited quantity o...
- KKR-Gland Pharma deal gets Competition Commission nodCompetition Commission of India (CCI) has given nod for the proposal, which involves multiple transactions, saying the deal does not raise ...
Load More
